Physician

Nancy Elizabeth Miller-Rivero, MD

According to 2025 Medicare claims, Nancy Miller-Rivero, MD (NPI: 1417053752) practices ophthalmology in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Dutchess, NY. Miller-Rivero uses personal NPI as billing NPI and primary practice location at 12601-3942.

Miller-Rivero's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 530 traditional Medicare patients, billed 12,281 HCPCS/CPT codes, and received $1,596,515 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 389 prescription claims across 91 beneficiaries totaling $61,338 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 21 records totaling $752. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$918K$1.8M2015 Medicare payment: $1,678,350 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,835,162 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,646,851 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,535,517 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,713,720 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,645,954 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,676,302 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,714,899 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,467,109 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,596,515 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156557,159$1,678,350
20166517,332$1,835,162
20176646,650$1,646,851
20186456,137$1,535,517
20196696,665$1,713,720
20206045,844$1,645,954
20215715,937$1,676,302
20226146,040$1,714,899
20235347,653$1,467,109
202453012,281$1,596,515

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$43K$86K2015 Drug cost: $50,775 (USD; Tot_Drug_Cst)2016 Drug cost: $51,289 (USD; Tot_Drug_Cst)2017 Drug cost: $50,525 (USD; Tot_Drug_Cst)2018 Drug cost: $60,428 (USD; Tot_Drug_Cst)2019 Drug cost: $68,964 (USD; Tot_Drug_Cst)2020 Drug cost: $76,397 (USD; Tot_Drug_Cst)2021 Drug cost: $85,781 (USD; Tot_Drug_Cst)2022 Drug cost: $55,563 (USD; Tot_Drug_Cst)2023 Drug cost: $68,943 (USD; Tot_Drug_Cst)2024 Drug cost: $61,338 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015100368$50,775
201698404$51,289
2017106414$50,525
2018109491$60,428
2019117442$68,964
2020100402$76,397
2021106382$85,781
202286297$55,563
202388340$68,943
202491389$61,338

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1311,110$656
67028Injection of drug into eye212912$99
92014Established patient complete exam of visual system188207$91
92012Established patient problem focused exam of visual system3551,050$73
92134Imaging of retina4501,283$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium511,126$5,881
ProlensaBromfenac Sodium14570$5,094
DifluprednateDifluprednate261,079$2,945
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol23942$2,247
Loteprednol EtabonateLoteprednol Etabonate13255$1,762

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$752Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nancy Elizabeth Miller-Rivero, MD?

Tedicare shows public-source Medicare data for Nancy Elizabeth Miller-Rivero, MD (NPI 1417053752), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nancy Elizabeth Miller-Rivero, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nancy Elizabeth Miller-Rivero, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Nancy Elizabeth Miller-Rivero, MD have Open Payments data?

Nancy Elizabeth Miller-Rivero, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.